[go: up one dir, main page]

BRPI0411855A - comprimido compreendendo fluvastatina e carmelose cálcica - Google Patents

comprimido compreendendo fluvastatina e carmelose cálcica

Info

Publication number
BRPI0411855A
BRPI0411855A BRPI0411855-3A BRPI0411855A BRPI0411855A BR PI0411855 A BRPI0411855 A BR PI0411855A BR PI0411855 A BRPI0411855 A BR PI0411855A BR PI0411855 A BRPI0411855 A BR PI0411855A
Authority
BR
Brazil
Prior art keywords
fluvastatin
tablet
calcium carmelose
carmelose
calcium
Prior art date
Application number
BRPI0411855-3A
Other languages
English (en)
Inventor
Tomoyuki Uehara
Kenji Taguchi
Kenichi Kitaoka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0411855A publication Critical patent/BRPI0411855A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPRIMIDO COMPREENDENDO FLUVASTATINA E CARMELOSE CáLCICA". A presente invenção refere-se a um comprimido contendo fluvastatina, em particular um comprimido contendo fluvastatina que possui excelente propriedade de desintegração e boa biodisponibilidade. O comprimido contendo fluvastatina caracteriza-se por compreender carmelose cálcica como agente de desintegração.
BRPI0411855-3A 2003-06-25 2004-06-24 comprimido compreendendo fluvastatina e carmelose cálcica BRPI0411855A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25
PCT/EP2004/006865 WO2005000276A1 (en) 2003-06-25 2004-06-24 Tablet comprising fluvastatin and carmellose calcium

Publications (1)

Publication Number Publication Date
BRPI0411855A true BRPI0411855A (pt) 2006-08-29

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411855-3A BRPI0411855A (pt) 2003-06-25 2004-06-24 comprimido compreendendo fluvastatina e carmelose cálcica

Country Status (21)

Country Link
US (1) US20090117181A1 (pt)
EP (1) EP1641440B1 (pt)
KR (1) KR20060030480A (pt)
CN (1) CN1809342A (pt)
AT (1) ATE471713T1 (pt)
AU (1) AU2004251439B2 (pt)
BR (1) BRPI0411855A (pt)
CA (1) CA2529447A1 (pt)
CO (1) CO5650224A2 (pt)
DE (1) DE602004027808D1 (pt)
EC (1) ECSP056238A (pt)
IL (1) IL172531A0 (pt)
IS (1) IS8249A (pt)
MA (1) MA27889A1 (pt)
MX (1) MXPA05013943A (pt)
NO (1) NO20060261L (pt)
NZ (1) NZ544119A (pt)
RU (1) RU2361582C2 (pt)
TN (1) TNSN05330A1 (pt)
WO (1) WO2005000276A1 (pt)
ZA (1) ZA200509930B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1825847A3 (en) * 2006-02-24 2008-01-23 Teva Pharmaceutical Industries Ltd Fluvastatin sodium pharmaceutical compositions
US9744127B2 (en) * 2010-10-12 2017-08-29 Bayer Intellectual Property Gmbh Non-starch based soft chewables
JP5988963B2 (ja) 2011-04-12 2016-09-07 沢井製薬株式会社 ピタバスタチン含有製剤及びその製造方法
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU217629B (hu) * 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
CA2399463A1 (en) * 2000-02-10 2001-08-16 Takeda Chemical Industries, Ltd. Combination drug
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
EP1329217A4 (en) * 2000-10-06 2007-04-04 Takeda Pharmaceutical Solid preparations

Also Published As

Publication number Publication date
IS8249A (is) 2006-01-20
IL172531A0 (en) 2006-04-10
MXPA05013943A (es) 2006-02-24
CA2529447A1 (en) 2005-01-06
TNSN05330A1 (en) 2007-07-10
NZ544119A (en) 2008-04-30
WO2005000276A1 (en) 2005-01-06
ATE471713T1 (de) 2010-07-15
AU2004251439A1 (en) 2005-01-06
EP1641440A1 (en) 2006-04-05
MA27889A1 (fr) 2006-05-02
RU2006101889A (ru) 2007-08-10
ECSP056238A (es) 2006-04-19
AU2004251439B2 (en) 2008-09-11
EP1641440B1 (en) 2010-06-23
KR20060030480A (ko) 2006-04-10
DE602004027808D1 (de) 2010-08-05
CO5650224A2 (es) 2006-06-30
ZA200509930B (en) 2007-01-31
RU2361582C2 (ru) 2009-07-20
US20090117181A1 (en) 2009-05-07
NO20060261L (no) 2006-01-18
CN1809342A (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
NL1021822A1 (nl) Tamsulosinetabletten.
BRPI0411855A (pt) comprimido compreendendo fluvastatina e carmelose cálcica
ITMI20032170A1 (it) Tagliacimosse.
NL1025055A1 (nl) Verbeterd lampontwerp.
ES1050183Y (es) Zapato con pala y plantilla reemplazables.
NL1024812A1 (nl) Lampenkap.
ES1051309Y (es) Desmenuzador de especias.
ES1055913Y (es) Linterna.
ES1053421Y (es) Linterna.
ES1053557Y (es) Luminaria vertical empotrable.
ES1052590Y (es) Quiosco-consigna.
ES1052131Y (es) Luminaria estanca mejorada.
ES1053652Y (es) Luminaria empotrable.
ES1052628Y (es) Extintor instantaneo.
SE0202435D0 (sv) Lykta, särskilt gravlykta
ES1052719Y (es) Lampara dinamica.
ES1053053Y (es) Destoconador vertical.
ITTO20020103U1 (it) Lampada da arredamento.
ES1052052Y (es) Brida.
ES1051893Y (es) Alarma vecinal.
ITSS20020004A1 (it) Paella algherese.
ITMI20020288A1 (it) Do.re.mi
ES1055305Y (es) Lampara.
ES1053835Y (es) Luminaria de techo.
ES1052029Y (es) Balin-proyectil.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.